Abstract
The rapid uptake and elimination of volatile anaesthetics such as sevoflurane means that these agents are convenient for induction and maintenance of general anaesthesia in adults and children. In the current economic climate, strategies to reduce drug costs associated with anaesthesia are becoming increasingly important. The amount of volatile agent used, and therefore the cost of the anaesthetic procedure, is directly proportional to the rate of fresh gas flow used during the surgical procedure. Consequently, reducing the rate of flow is a simple way to reduce the cost of anaesthesia, as long as other risks (e.g. haemodynamic) are managed. Several presentations focused on the cost implications of reduced flow sevoflurane administration at the 72nd Clinical and Scientific Congress of the International Anaesthesia Research Society [Orlando, US; March 1998].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
